{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:51:29Z","timestamp":1772229089087,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11864-013-0249-1","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T08:18:11Z","timestamp":1375172291000},"page":"528-538","source":"Crossref","is-referenced-by-count":46,"title":["Diagnosis and Management of Paraneoplastic Neurologic Disorders"],"prefix":"10.1007","volume":"14","author":[{"given":"Myrna R.","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,31]]},"reference":[{"key":"249_CR1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1468-1331.2011.03380.x","volume":"18","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA: Neuropathy and paraproteins: review of a complex association. Eur J Neurol 2011, 18:1291\u20131298. A recent review of the neuropathic syndromes associating with serum paraproteinemias.","journal-title":"Eur J Neurol"},{"key":"249_CR2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1529-8027.2010.00283.x","volume":"15","author":"E Nobile-Orazio","year":"2010","unstructured":"Nobile-Orazio E: Update on neuropathies associated with monoclonal gammopathy of undetermined significance (2008\u20132010). J Peripher Nerv Syst 2010, 15:302\u2013306. A review of the neuropathies associated with MGUS including clincial features and summaries of two recent clincial trials that failed to show benefit of rituximab.","journal-title":"J Peripher Nerv Syst"},{"key":"249_CR3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"249_CR4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J: Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010, 257:509\u2013517. A detailed review of anti-neuronal antibodies described in PND of the central nervous system addressing diagnostic value and potentials pitfalls and limitations of their use.","journal-title":"J Neurol"},{"key":"249_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00415-004-0317-3","volume":"251","author":"MC Vigliani","year":"2004","unstructured":"Vigliani MC, Magistrello M, Polo P, Mutani R, Chio A. Risk of cancer in patients with Guillain-Barre syndrome (GBS). A population-based study. J Neurol. 2004;251:321\u20136.","journal-title":"J Neurol"},{"key":"249_CR6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4065\/78.11.1363","volume":"78","author":"ND Lawn","year":"2003","unstructured":"Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363\u20138.","journal-title":"Mayo Clin Proc"},{"key":"249_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","volume":"13","author":"E Tuzun","year":"2007","unstructured":"Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261\u201371.","journal-title":"Neurologist"},{"key":"249_CR8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","volume":"128","author":"BM Ances","year":"2005","unstructured":"Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764\u201377.","journal-title":"Brain"},{"key":"249_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11307-008-0134-7","volume":"10","author":"S Basu","year":"2008","unstructured":"Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10:131\u20137.","journal-title":"Mol Imaging Biol"},{"key":"249_CR10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RLU.0b013e3182815f28","volume":"38","author":"AJ Clapp","year":"2013","unstructured":"Clapp AJ, Hunt CH, Johnson GB, Peller PJ: Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes. Clin Nucl Med 2013, 38:241\u2013247. Shows how qualitative and semiquantitative analyses of brain FDG-PET studies may be helpful to evaluate patients with PND, especially patients with a normal MRI.","journal-title":"Clin Nucl Med"},{"key":"249_CR11","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00262-009-0690-y","volume":"58","author":"SE Monstad","year":"2009","unstructured":"Monstad SE, Knudsen A, Salvesen HB, Aarseth JH, Vedeler CA. Onconeural antibodies in sera from patients with various types of tumours. Cancer Immunol Immunother. 2009;58:1795\u2013800.","journal-title":"Cancer Immunol Immunother"},{"key":"249_CR12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol"},{"key":"249_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424\u201334.","journal-title":"Ann Neurol"},{"key":"249_CR14","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","volume":"30","author":"EG Hughes","year":"2010","unstructured":"Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866\u201375.","journal-title":"J Neurosci"},{"key":"249_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al.: Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12:157\u2013165. A series of almost 600 patients with anti-NMDA receptor encephaltis describing disease presentation, spectrum of symptoms, immunotherapies and responses, and long-term outcome.","journal-title":"Lancet Neurol"},{"key":"249_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(99)00029-5","volume":"163","author":"K Tanaka","year":"1999","unstructured":"Tanaka K, Tanaka M, Inuzuka T, Nakano R, Tsuji S. Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci. 1999;163:159\u201362.","journal-title":"J Neurol Sci"},{"key":"249_CR17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","volume":"68","author":"F Keime-Guibert","year":"2000","unstructured":"Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"249_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1215\/S1152851703000395","volume":"6","author":"S Vernino","year":"2004","unstructured":"Vernino S, O\u2019Neill BP, Marks RS, O'Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro-oncol. 2004;6:55\u201362.","journal-title":"Neuro-oncol"},{"key":"249_CR19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831\u201344.","journal-title":"Brain"},{"key":"249_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13:682\u201390.","journal-title":"Eur J Neurol"},{"key":"249_CR21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/jnnp.2009.177865","volume":"81","author":"F Broekhoven van","year":"2010","unstructured":"van Broekhoven F, de Graaf MT, Bromberg JE, et al. Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2010;81:1341\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"249_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","volume":"253","author":"S Shams\u2019ili","year":"2006","unstructured":"Shams\u2019ili S, de Beukelaar J, Gratama JW, et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol. 2006;253:16\u201320.","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"249_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","volume":"158","author":"A Durandy","year":"2009","unstructured":"Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol. 2009;158 Suppl 1:2\u201313.","journal-title":"Clin Exp Immunol"},{"key":"249_CR24","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2009.157","volume":"66","author":"MP Martin","year":"2009","unstructured":"Martin MP, Cravens PD, Winger R, et al. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Arch Neurol. 2009;66:1016\u201320.","journal-title":"Arch Neurol"},{"key":"249_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-009-9335-3","volume":"30","author":"MR Pranzatelli","year":"2010","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL, Colliver JA. Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus. J Clin Immunol. 2010;30:106\u201313.","journal-title":"J Clin Immunol"},{"key":"249_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1006136219490","volume":"40","author":"TT Batchelor","year":"1998","unstructured":"Batchelor TT, Platten M, Hochberg FH. Immunoadsorption therapy for paraneoplastic syndromes. J Neurooncol. 1998;40:131\u20136.","journal-title":"J Neurooncol"},{"key":"249_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/adc.2010.204792","volume":"97","author":"A Brunklaus","year":"2012","unstructured":"Brunklaus A, Pohl K, Zuberi SM, de Sousa C. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome. Arch Dis Child. 2012;97:461\u20133.","journal-title":"Arch Dis Child"},{"key":"249_CR28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/pbc.22226","volume":"53","author":"CE Catsman-Berrevoets","year":"2009","unstructured":"Catsman-Berrevoets CE, Aarsen FK, van Hemsbergen ML, et al. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up. Pediatr Blood Cancer. 2009;53:1048\u201353.","journal-title":"Pediatr Blood Cancer"},{"key":"249_CR29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jpeds.2012.10.011","volume":"162","author":"T Armangue","year":"2013","unstructured":"Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013;162:850\u20136.","journal-title":"J Pediatr"},{"key":"249_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004150050054","volume":"244","author":"M Drlicek","year":"1997","unstructured":"Drlicek M, Bianchi G, Bogliun G, et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol. 1997;244:85\u20139.","journal-title":"J Neurol"},{"key":"249_CR31","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138\u201348.","journal-title":"Brain"},{"key":"249_CR32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-002-0706-4","volume":"249","author":"SP Sillevis","year":"2002","unstructured":"Sillevis SP, Grefkens J, De Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis\/sensory neuronopathy. J Neurol. 2002;249:745\u201353.","journal-title":"J Neurol"},{"key":"249_CR33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","volume":"51","author":"S Vernino","year":"2002","unstructured":"Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002;51:625\u201330.","journal-title":"Ann Neurol"},{"key":"249_CR34","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","volume":"340","author":"R Voltz","year":"1999","unstructured":"Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med. 1999;340:1788\u201395.","journal-title":"N Engl J Med"},{"key":"249_CR35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archneurol.2010.209","volume":"67","author":"SJ Pittock","year":"2010","unstructured":"Pittock SJ, Parisi JE, McKeon A, et al. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010;67:1109\u201315.","journal-title":"Arch Neurol"},{"key":"249_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","volume":"74","author":"F Graus","year":"1997","unstructured":"Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. J Neuroimmunol. 1997;74:55\u201361.","journal-title":"J Neuroimmunol"},{"key":"249_CR37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E Graaff de","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71:815\u201324.","journal-title":"Ann Neurol"},{"key":"249_CR38","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.4049\/jimmunol.175.11.7755","volume":"175","author":"R Raju","year":"2005","unstructured":"Raju R, Foote J, Banga JP, et al. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol. 2005;175:7755\u201362.","journal-title":"J Immunol"},{"key":"249_CR39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.10462","volume":"53","author":"L Bataller","year":"2003","unstructured":"Bataller L, Rosenfeld MR, Graus F, et al. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol. 2003;53:347\u201353.","journal-title":"Ann Neurol"},{"key":"249_CR40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1423.027","volume":"1110","author":"A Kirsten","year":"2007","unstructured":"Kirsten A, Beck S, Fuhlhuber V, et al. New autoantibodies in pediatric opsoclonus myoclonus syndrome. Ann N Y Acad Sci. 2007;1110:256\u201360.","journal-title":"Ann N Y Acad Sci"},{"key":"249_CR41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437\u201343.","journal-title":"Brain"},{"key":"249_CR42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archophthalmol.2009.24","volume":"127","author":"HA Ferreyra","year":"2009","unstructured":"Ferreyra HA, Jayasundera T, Khan NW, et al.: Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol 2009, 127:390\u2013397. A relatively large series of patients with autoimmune retinopathies treated with immunotherapy demonstrating subgroups of responsive patients.","journal-title":"Arch Ophthalmol"},{"key":"249_CR43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11940-009-0057-x","volume":"12","author":"SF Powell","year":"2010","unstructured":"Powell SF, Dudek AZ. Treatment of melanoma-associated retinopathy. Curr Treat Options Neurol. 2010;12:54\u201363.","journal-title":"Curr Treat Options Neurol"},{"key":"249_CR44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11940-012-0213-6","volume":"15","author":"A Sonderen van","year":"2013","unstructured":"van Sonderen A, Wirtz PW, Verschuuren JJ, Titulaer MJ: Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in Myasthenia Gravis, Lambert-Eaton myasthenic syndrome, and neuromyotonia. Curr Treat Options Neurol 2013, 15:224\u2013239. A very recent review of these three syndromes, clinical features, immune-associations, treatment responses, and cancer assocaitions.","journal-title":"Curr Treat Options Neurol"},{"key":"249_CR45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","volume":"343","author":"S Vernino","year":"2000","unstructured":"Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847\u201355.","journal-title":"N Engl J Med"},{"key":"249_CR46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","volume":"69","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Huijbers MG, Bar V, et al. Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69:303\u201311.","journal-title":"Ann Neurol"},{"key":"249_CR47","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776\u201385.","journal-title":"Lancet Neurol"},{"key":"249_CR48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67\u201376.","journal-title":"Lancet Neurol"},{"key":"249_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"SP Sillevis","year":"2000","unstructured":"Sillevis SP, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"249_CR50","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77:1698\u2013701.","journal-title":"Neurology"},{"key":"249_CR51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96\u2013100.","journal-title":"Lancet"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-013-0249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-013-0249-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-013-0249-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:34:26Z","timestamp":1559417666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-013-0249-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["249"],"URL":"https:\/\/doi.org\/10.1007\/s11864-013-0249-1","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}